EUCTR2011-006019-73-GB
Active, not recruiting
Phase 1
Randomized, double blind, placebo-controlled trial of Creon in patients with low faecal pancreatic elastase - Creon use in patients with low faecal pancreatic elastase
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Pancreatic Insufficiency
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Enrollment
- 2
- Status
- Active, not recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with chronic diarrhoea (\>3 loose/ liquid motions a day for more than 4 weeks)
- •Patients with a low faecal elastase (\<200 µg/g),
- •Patients aged 16 years or over
- •Patients able to give written consent to participate
- •Patients not currently on Creon
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 35
- •F.1\.3 Elderly (\>\=65 years) yes
Exclusion Criteria
- •Patients with normal faecal elastase (\> 201µg/g),
- •Patients under the age of 16
- •Patients allergic to pork or any pig product (advice from the drug manufacturer)
- •Patients that are pregnant or are breast\-feeding
- •Patients taking alternative medication that could affect bowel frequency
- •Where an alternative diagnosis for the chronic diarrhoea is established, these patients will be excluded from the trial
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Randomized, double blind, placebo-controlled trial of ubiquinol in a statin-induced mitochondrial dysfunction model in healthy volunteers.NL-OMON41941Centre for Human Drug Research28
Completed
Phase 3
A clinical trial to study whether zinc decreases the frequency of disease relapses in patients with frequently relapsing nephrotic syndromeHealth Condition 1: null- Frequently relapsing nephrotic syndromeCTRI/2008/091/000057I114
Active, not recruiting
Not Applicable
A clinical trial to compare the effectiveness and safety of treating the initial episode of nephrotic syndrome in children for a duration of three months versus six monthsHealth Condition 1: null- Initial episode of steroid sensitive nephrotic syndromeCTRI/2010/091/001095Indian Council of Medical Research168
Completed
Not Applicable
Randomised, double blind, placebo-controlled trial for testing the efficacy of a botanical formulation in reducing cold and flu symptomsCommon cold and fluInfections and InfestationsISRCTN09166218Radix Bioresearch Corporation (USA)60
Active, not recruiting
Not Applicable
Randomized, double-blind, placebo controlled trial on the efficacy of montelukast in exercise-induced asthma in children - MONTEIAEUCTR2005-004984-43-ITIVERSITA DEGLI STUDI DI UDINE22